Quarterly ResultJul 14, 2026, 04:12 PM
Kestra Medical Q4 Revenue +66% to $28.6M; FY26 Revenue +59% to $95.1M
AI Summary
Kestra Medical Technologies reported strong financial results for the fourth quarter and fiscal year ended April 30, 2026. Q4 revenue increased 66% to $28.6 million, and FY26 revenue grew 59% to $95.1 million, with significant gross margin expansion. The company also provided positive FY27 revenue guidance of $137 million, representing 44% growth. Additionally, Kestra entered into a new five-year senior secured term loan facility of up to $200 million, replacing its prior loan agreement.
Key Highlights
- FY26 revenue increased 59% to $95.1 million compared to FY25.
- Q4 2026 revenue increased 66% to $28.6 million compared to prior year.
- FY27 revenue guidance set at $137 million, a 44% increase over FY26.
- FY26 gross margin expanded to 51.4% from 40.5% in FY25.
- Q4 2026 gross margin expanded to 54.8% from 44.3% in prior year.
- Entered new senior secured term loan facility of up to $200.0 million.
- Tranche A Loan of $75.0 million was funded on July 10, 2026.
- FY26 GAAP net loss was $131.6 million.
Price Impact
More from KMTS